Nephrogenic Systemic Fibrosis - FDA Gadolinium Report
http://www.fda.gov/bbs/topics/NEWS/2007/NEW01638.html
The U.S. Food and Drug Administration (FDA) has asked manufacturers to include a new boxed warning on the product labeling of all gadolinium-based contrast agents which are used to enhance the quality of magnetic resonance imaging (MRI). The requested gadolinium warning would state that patients with severe kidney insufficiency who receive gadolinium-based agents are at risk for developing a debilitating, and a potentially fatal disease known as nephrogenic systemic fibrosis (NSF). In addition, it would state that patients just before or just after liver transplantation, or those with chronic liver disease, are also at risk for developing nephrogenic systemic fibrosis (NSF) if they are experiencing kidney insufficiency of any severity. “FDA has been carefully monitoring potential safety signals related to these contrast agents after receiving reports about the risk of this potentially life-threatening disease,” said Steven Galson, M.D., M.P.H., director of FDA’s Center for Drug Evaluation and Research. “This latest action demonstrates FDA’s continuing vigilance about ensuring the safety of drug products once they enter the marketplace.” Patients with NSF develop thickening of the skin and connective tissues that inhibits their ability to move and may result in broken bones. Other organs are at risk of thickening as well. The cause of nephrogenic systemic fibrosis (NSF) is not known and there is no consistently effective treatment of this condition.
Nephrogenic Fibrosing Dermopathy Research
http://www.icnfdr.org/
Nephrogenic Systematic Fibrosis (NSF) and Nephrogenic Fibrosing Dermopathy (NFD) medical research site.
MRI Contrast Agent Linked to Rare Disease
http://www.docguide.com/news/content.nsf/news/852571020057CCF68525726E006681B9
New research has shown a possible association between a popular magnetic resonance imaging (MRI) contrast agent and the incidence of a rare disease called Nephrogenic Systemic Fibrosis (NSF) in patients with kidney disease.
National Kidney Foundation (NKF)
http://www.kidney.org/kidneyDisease/
Get the facts about kidney disease – learn about early detection, kidney problems, kidney failure, kidney diseases, kidney dialysis and other valuable kidney information.
Nephrogenic Systemic Fibrosis Lawsuit
http://www.mri-gadolinium-lawsuits.com/
If you or a loved one had a MRI or a MRA, and a Gadolinium-based contrast dye, medium or agent was used to enhance the MRI image, then your health may be at risk. If you developed Nephrogenic Systemic Fibrosis (NSF), Nephrogenic Fibrosing Dermopathy (NFD), skin problems, skin tightening, severe joint problems, kidney failure, or renal failure, then you may be eligible to collect money damages for your injuries. Please contact us by calling 1-800-883-9858 or follow the link below for a free and confidential case evaluation.
